Home Analyst Ratings Intellicheck Stock Gets Reiterated At HC Wainwright & Co.. It's Still...

Intellicheck [IDN] Stock Gets Reiterated At HC Wainwright & Co.. It’s Still Buy

HC Wainwright & Co. maintained its Intellicheck [IDN] rating to the equivalent of Buy but changed the price target to $18.0 from $12, in a research note dated 2021-01-11. That figure represents around a 53.98% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with H.C. Wainwright’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in early November. In addition, B. Riley FBR launched coverage on October 18, 2019. The research firm rated IDN “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Intellicheck Inc. [NASDAQ:IDN] a Good Buy Right Now?

It should be noted that IDN technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 96% Buy in the past month. Data from Intellicheck Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 0.23 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.2 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.16 million shares.

IDN Price Performance

On Wall Street, Intellicheck Inc. [NASDAQ:IDN] finished Friday’s session down -2.34% at $11.69. The stock went up to $12.16 at the same session while its lowest single day price was $11.14. In the last five days, it saw a rise of about 2.50%, Intellicheck Inc. shares gained by almost 2.50% since the beginning of the year. However, the share price has dropped to as low as -8.03% below its one year high. On 01/06/21, the company shares recorded $12.71, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $10.75. The company’s shares have inclined by 32.84% in the past year. The 50-day SMA achieved is $9.87 while the 200-day SMA is $7.40. Volume dropped to 0.21 million from 0.24 million in the previous session.

IDN Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 11.17 level, and in case of violation of this particular level, it will cause more drop to 10.64 level. On the upper level, 12.68 is still the key resistance. The stock may increase to the subsequent resistance at 12.19. The Relative Strength Index (RSI) pinned on the 14-day chart is 65.25, implying a neutral technical stance while the MACD stands at 0.93, meaning price will decrease in the next trading period. Percent R indicator moved to 31.78%, implying low price movement. Stochastic %K at 76.76% suggest selling the stock.

What is the short interest in Intellicheck Inc.?

Short interest in the Intellicheck Inc. stock has surged, increasing by 0.19 million shares to total 0.37 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 0.56 million, data from Yahoo Finance shows. The decrease of -50.02% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 2.46% of the overall float for the stock.

Intellicheck Inc.’s Biggest Shareholders: Who Owns Intellicheck Inc. [IDN]?

Filings by Bleichroeder LP showed that the firm now holds a total of 2,228,678 shares or roughly 12.11% of the outstanding IDN shares. This means their shares have reduced by -509,636 from the 2,228,678 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Clear Harbor Asset Management LLC updated stake is worth $14,696,357. Details in the latest 13F filings reveal that BlackRock Fund Advisors acquired their 4.12% stake valued at $7,101,981 while The Vanguard Group, Inc. cut theirs at $6,484,450. During the last quarter, BlackRock Fund Advisors raised 28,629 of its shares in Intellicheck Inc. while The Vanguard Group, Inc. sold -1,253 shares. The Heartland Advisors, Inc.’s holdings currently number 500,000 shares at $5845000.0. According to the firm’s last 13F report, Herald Investment Management Ltd. shares in the company at filing stood at 372,700 shares, roughly $3,659,914.

IDN Earnings Forecast For The Current Quarter

Intellicheck Inc. [IDN] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $3.33M and an earnings per share of $0.02 for Dec 2020. Looking further ahead, the company is expected to report revenue of $3.49M at an EPS of $0.02 for Mar 2021. The estimates represent upside of 55.80% and 1250.00% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

IDN Earnings Estimates For The Current Year

For the financial year, Intellicheck Inc. [NASDAQ:IDN] is expected to bring in revenue of $10.99M. The returns are nearly $3.33 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at -0.02, higher than that of FY19 by $0.14. Estimates put this year’s earnings growth at 87.50%, 1,250.00% for the next, and at an annual 10.00% over the next 5-year period. As for sales, forecasts are for an increase of 43.40% in the current fiscal year and a further 55.80% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

ReTo Eco-Solutions, Inc. (RETO) Stock Fell 6% In Pre-Market Trading

The provider of technology solutions around ecological environments ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has been facing a drop in its stock price in pre-market...

Fulgent Genetics (FLGT) Stock Rocketed 34.46% In Extended Trading Following Strong Financial Results

Shares of the testing services and comprehensive testing solutions technology company Fulgent Genetics, Inc. (NASDAQ: FLGT) rocketed 34.46% in the after-hour trades on Thursday....

After An Impressive 300% Rally, Why Did Second Sight Medical Products (EYES) Get Dropped After-Hours?

Shares of the implantable visual prosthetics company, Second Sight Medical Products, Inc. (NASDAQ: EYES) have seen a fall of -12.61% in after-hours trading on...

After-Hours Market: More Gains For Bionano Genomics (BNGO)

Bionano Genomics, Inc. (Nasdaq: BNGO) saw its stock price continue rising even after the ring of the bell on Friday. The company gained 7.13%...

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.